Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

NCT06738771 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Pseudomonas Infections
Pseudomonas Aeruginosa
Prognosis
Drug Resistance, Multiple, Bacterial
Antibacterial Agents
Beta-lactam Antibiotics

Sponsor

Centre Hospitalier Régional d'Orléans